US2010267121A1PendingUtilityA1

Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates

Assignee: VICAL INCPriority: Feb 21, 2001Filed: Dec 11, 2009Published: Oct 21, 2010
Est. expiryFeb 21, 2021(expired)· nominal 20-yr term from priority
Inventors:Gabriele Hahn
C12N 2710/16161C12N 2710/16143C12N 2710/16134A61K 39/12C12N 7/00C12N 2710/16132A61K 48/00C12N 15/86A61K 39/245
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A recombinant vector containing infectious genome of human cytomegalovirus (HCMV) and being useful for the production of reconstituted HCMV virus retaining phenotypic characteristics of a clinical virus isolate including the ability to grow on endothelial cells and to induce microfusion is characterized in that it is obtainable by inserting DNA from a clinical isolate of HCMV virus into a bacterial cloning vehicle. Such vector can be used e.g., for production of reconstituted HCMV virus retaining the phenotypic characteristics of a parental clinical isolate and for studying genes and functions of genes of HCMV virus. A further aspect are mutant viruses and inter alia their use for studying aspects of infectivity of HCMV virus.

Claims

exact text as granted — not AI-modified
1 . Recombinant vector containing infectious genome of human cytomegalovirus (HCMV) and being useful for the production of reconstituted HCMV virus retaining phenotypic characteristics of a clinical virus isolate including the ability to grow on endothelial cells, to induce microfusion and to spread viral material from HUVEC to PMNL, characterized in that it is obtainable by inserting DNA from a clinical isolate of HCMV virus into a bacterial cloning vehicle. 
     
     
         2 . Recombinant vector according to  claim 1  which contains the complete infectious DNA of HCMV. 
     
     
         3 . Recombinant vector according to  claim 1 , characterized in that the bacterial cloning vehicle contains DNA sequences which are homologous to the HCMV DNA and insertion is effected by homologous recombination. 
     
     
         4 . Recombinant vector according to  claim 1 , wherein the bacterial cloning vehicle is a BAC system vector. 
     
     
         5 . Recombinant vector according to  claim 1  and designated FIX-Bac-7. 
     
     
         6 . Bacterial cell line containing a recombinant vector according to  claim 1 . 
     
     
         7 . Bacterial cell line according to  claim 6  which is an  E. coli  cell line. 
     
     
         8 . Bacterial cell line according to  claim 6 , designated FIX-Bac-7- E. coli  DH 10B and deposited as DSM 13958 containing at least one copy of FIX-Bac-7. 
     
     
         9 . A bacterial cell line according to  claim 6  for the production of reconstituted HCMV Virus retaining the phenotypic characteristics of a parental clinical isolate including the ability to grow on endothelial cells, to induce microfusion and to spread viral material from HUVEC to PMNL.

Join the waitlist — get patent alerts

Track US2010267121A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.